Latest Denosumab Stories
OSTORA, a new oral drug made of salmon calcitonin, was in its third phase of study to determine if it effectively treated postmenopausal osteoporosis. The researchers deemed it safe and effective.
THOUSAND OAKS, Calif., Aug.
NEW YORK, July 28, 2011 /PRNewswire/ -- A study published by ITG this week revealed that U.S.
THOUSAND OAKS, Calif., July 15, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the European Commission (EC) has granted marketing authorization for XGEVAÂ® (denosumab) for the prevention of skeletal-related events (SREs) (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with bone metastases from solid tumors.
THOUSAND OAKS, Calif., June 27, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S.
- A hairdresser.